Broadstreet HEOR

Broadstreet Health Economics & Outcomes Research (Vancouver, Canada) is a consultancy running health-economics and real-world-evidence studies for Pfizer, Bayer, Boehringer Ingelheim, Takeda, Madrigal, Alexion/AstraZeneca, Bristol-Myers Squibb, Sarepta, Taysha, Biohaven and others. - US patient PHI: Medicaid (11.3M rows: DOB, race, diagnoses, NDC drugs, payments), Veradigm/Allscripts EHR tables, licensed IBM MarketScan / Optum Clinformatics data. - Production Alexiondb (PostgreSQL): schema + claims rows. - Live SQL Server credentials of client Taysha Gene Therapies (production DB irsf-nhs-prod-db, public IP). - Confidential pharma materials: unpublished Boehringer Ingelheim slides, Takeda manuscript, Bayer CEM models, Madrigal reports, Pfizer/VA emails. - Staff personal documents.